Author

V Teich

Observed names: V. Teich, V.T. Teich, VD Teich

Observed institution: Insper

OpenAlex ID: A5021337347

Retrospective cost analysis of breast cancer patients treated in a Brazilian outpatient cancer center (OCC).

2010 · N. Teich, C. Pepe, et al. · Journal of Clinical Oncology · 4

PCN86 Cost-Effectiveness Analysis of Abiraterone for the Treatment of Advanced Prostate Cancer Under the Brazilian Private Health Care System

2012 · M.L. Pereira, L.S.K. Bahmdouni, et al. · Value in Health · 3

PDF

Resource use patterns and costs associated with the treatment of myelofibrosis, polycythemia vera and essential trombocythemia in the brazilian public health care system

2013 · M.R. Alves, V. Teich, et al. · Value in Health · 2

PDF

Pcn72 Economic Evaluation of Sunitinib Vs. Interferon-a and Bevacizumab + Interferon-a in the Treatment of Metastatic Renal Cell Carcinoma (ccrm) – Brazilian Private Health System Perspective

2010 · V Teich, CM Hashizume, et al. · Value in Health · 2

PDF

Romiplostim Cost Per Response In Itp Treatment In the Brazilian Health Care System

2014 · C. Pepe, V. Teich, et al. · Value in Health · 1

PCN48 Costs Associated to Treatment of Metastatic HER2 Positive Breast Cancer After Progression to Trastuzumab Under the Perspective of the Brazilian Private Health Care System

2012 · O.A.C. Clark, V. Teich · Value in Health · 1

PIN58 Cost-Effectiveness Analysis of Pneumococcal 13-Valente Conjugate Vaccine Versus Pneumococcal 10-Valente Conjugate Vaccine in the Pediatric Immunization Routine, from the São Paulo State Public Health Care System (Brazil)

2011 · C. Pepe, V. Teich, et al. · Value in Health · 1

Pcn40 Retrospective Cost and Outcome Analysis of Breast Cancer Patients Treated in a Brazilian Outpatient Cancer Center (occ)

2010 · N Teich, CPR Souza, et al. · Value in Health · 1

Pcv12 Cost-effectiveness Analysis of Dabigatran Etexilate Versus Enoxaparin for the Prevention of Venous Thromboembolism After Total Hip Replacement Under the Brazilian Public Health Care System Perspective

2009 · RA Fernandes, FF Quintella, et al. · Value in Health · 1

PDF

Pcn62 Cost Analysis of Hormone Receptor Positive, Advanced Breast Cancer Treatment With Endocrine Therapy Versus Chemotherapy in the Brazilian Public Health Care System (bphs)

2009 · E Abdo Filho, M Takemoto, et al. · Value in Health · 1

Pcn7 Metastatic Breast Cancer Treatment Patterns and Costs of Outpatient Care Under the Brazilian Private Health Care System Perspective

2009 · V Teich, N Teich, et al. · Value in Health · 1

Economic Evaluation of Recombinant Factor VIII FC Fusion Protein (RFVIIIFC) for Immune Tolerance Induction (ITI) in Patients with Hemophilia a WHO Develop Inhibitors Under the Brazilian Unified Health System (SUS) Perspective

2018 · V Teich, N Li, et al. · Value in Health

Statistics and Costs of Emergency Care Related to External Causes in One Hospital of Rio De Janeiro City

2017 · RA Fernandes, MV Sauberman, et al. · Value in Health

PDF

P449 Patient support program for adalimumab-treated patients with Crohn's disease in Brazil: impact on patients' adherence and persistence

2017 · V. Teich, R. Arinelli, et al. · Journal of Crohn s and Colitis

Modelo De Terapia Assistida Na Dispensação De Imunobiológicos Para Artrite Reumatoide No Sus Reduz Despesas Pelo Uso Racional Dos Recursos

2017 · J.C.B. Moraes, C.G.S. Saad, et al. · Revista Brasileira de Reumatologia

Number Needed to Treat and Cost Per Clinically Meaningful Outcome of Enzalutamide and Abiraterone Acetate for The Treatment of Metastatic Castration-Resistant Prostate Cancer That Failed Androgen Deprivation Therapy in Brazil

2016 · AP Sasse, G Lopes, et al. · Value in Health

Adherence and Persistence among Patients Treated with First-Line Therapies for Relapsing-Remitting Multiple Sclerosis in Brazil

2015 · A Gulart, V Teich, et al. · Value in Health

Hospital Readmissions and Mortality Patterns in a Cohort with Heart Failure: 1 Year Follow-Up from the Brazilian Public Healthcare System Database

2015 · EW Asano, V Teich, et al. · Value in Health

PDF

PMS4 Comparative Analysis Between Costs and Clinical Response of Biologic Drugs for the Treatment of Rheumatoid Arthritis (RA)

2012 · C.R.D.O. Cantanheda, V.A. Romão, et al. · Value in Health

PMS13 Economic Model of Workplace Impacts of anti-Tnf therapy for Rheumatoid Arthritis in Brazil

2011 · V. Teich, L. Chaves, et al. · Value in Health

PCV8 Cost-Effectiveness and Budget Impact Analysis of Rivaroxaban in the Prevention of Thromboembolic Events in Patients Performing Hip and Knee Arthroplasty in Comparison with Dabigatran Under the Brazilian Private Health Care System Perspective

2011 · A. Schiola, A.P. Silva, et al. · Value in Health

PCV6 Cost-Effectiveness and Budget Impact Analysis of Rivaroxaban in the Prevention of Thromboembolic Events in Patients Performing Hip and Knee Arthroplasty in Comparison With Enoxaparin Under the Brazilian Private Health Care System Perspective

2011 · A. Schiola, A.P. Silva, et al. · Value in Health

PCV5 Cost-Effectiveness and Budget Impact Analysis of Rivaroxaban in the Prevention of Thromboembolic Events in Patients Performing Hip and Knee Arthroplasty in Comparison with No Treatment Under the Brazilian Private Health Care System Perspective

2011 · A. Schiola, A.P. Silva, et al. · Value in Health

PIN102 National Cost Savings from the Brazilian HIV/AIDS Antiretroviral Universal Access Program: Analysis Versus Canada and Australia

2011 · R.V. Becker, V. Teich, et al. · Value in Health

Pms72 Interactive Electronic Interfaces (iei): Bridging the Communication Gap by Translating Economic Analysis Results to Decision-makers Everyday Practice

2010 · M Marinho, A Schiola, et al. · Value in Health

Works count: 39

Citation count: 18

H-index: 2

I10-index: